COPD
« Previous EntriesStudy supports COPD link to systemic inflammation
Friday, June 4th, 2010Results from a Spanish population-based study support an independent association between chronic obstructive pulmonary disease (COPD) and low-grade systemic inflammation.
Patients with COPD are known to be at significantly greater risk for weight loss, skeletal muscle dysfunction, cardiovascular disease, depression, osteoporosis and other conditions compared with individuals without the respiratory condition. This has lead some authors […]
Evidence for CV benefits of inhaled corticosteroids in COPD ‘lacking’
Thursday, May 6th, 2010Source: MedWire News
A systematic review and meta-analysis of published studies has failed to find strong evidence to suggest that treatment with inhaled corticosteroids (ICSs) reduces risk for myocardial infarction (MI), cardiovascular (CV) death, or overall mortality in patients with chronic obstructive pulmonary disease (COPD).
ICSs are widely used in the treatment of patients with COPD, and […]
Inhaled Corticosteroids reduces mortality risk in COPD patients with pneumonia
Wednesday, May 5th, 2010The use of inhaled corticosteroids (ICS) is associated with reduced mortality among chronic obstructive pulmonary disease (COPD) patients with pneumonia, research suggests.
“Recent studies suggest that use of ICS in COPD may be associated with a higher incidence of pneumonia,” explain M Restrepo (University of Texas Health Science Center, San Antonio, USA) and team.
“However, it is […]
High-fiber diet linked to reduced risk for COPD
Tuesday, February 23rd, 2010Source: MedWire News
A diet high in fiber, particularly from cereals, is associated with a reduced risk for chronic obstructive pulmonary disease (COPD), researchers have found.
Previous studies have suggested that, in addition to smoking, general diet may also be associated with COPD risk. Indeed, a western-style diet, which is high in cured and red meats, […]
ICS treatment ‘does not reduce bone density in COPD patients’
Wednesday, December 9th, 2009Source: MedWire News
Inhaled corticosteriod (ICS) treatment has no significant effect on bone mineral density (BMD) in patients with chronic obstructive pulmonary disease (COPD), report researchers.
“Evidence suggests that the prevalence of osteoporosis in patients with COPD is high and potentially important,” explain Gary Ferguson (Pulmonary Research Institute of Southeast Michigan, Livonia, USA) and team.
But they […]
